The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.
Editor's note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Diabetic macular edema is still a very ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. UBX1325 met safety and efficacy endpoints at 24 weeks in ...
Sunir J. Garg, MD, shares his recent experience at the American Academy of Ophthalmology Annual Meeting in San Francisco and highlights two key takeaways. First, Dr Garg explores the ...
The eye is made up of several different parts. One of these parts is the retina, which is home to special nerve cells that respond to light. The macula is part of that network and is located in the ...
Patients with diabetic macular edema could be treated with brolucizumab with as much effectiveness as aflibercept. There were no clinically meaningful differences in visual outcomes when patients with ...
Soaanz is a loop diuretic with an extended duration of action lasting approximately 6 to 8 hours. The Food and Drug Administration (FDA) has approved Soaanz ® (torsemide) for the treatment of edema ...
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Macular Edema pipeline constitutes key companies continuously working towards developing Diabetic Macular Edema ...
ANI Pharmaceuticals announced the results of the NEW DAY clinical trial for ILUVIEN® (fluocinolone acetonide) in diabetic macular edema (DME) patients during the ASRS Annual Scientific Meeting. The ...
Peripheral edema, or swelling, has long been associated with certain conditions and research continues regarding causes and treatments for the swelling that occurs when fluid collects in tissue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results